Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection
Status:
Active, not recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to find out if adding triamcinolone (steroid) injection
at the participant's initial esophagogastroduodenoscopy (EGD) procedure will improve the
opening of their esophagus and decrease the need for repeat dilations.
Phase:
N/A
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute